Profile
SXTP VRTX REGN SGEN ALNY ARGX
Company Name 60 Degrees Pharmaceuticals, Inc. Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Seagen Inc. Alnylam Pharmaceuticals, Inc. argenx SE
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $3.45M $116.96B $58.10B $43.15B $41.50B $33.28B
Employees 0.00K 6.10K 15.16K 3.26K 2.23K 1.60K
CEO Geoffrey Stuart Dow Dr. Reshma Kewalramani FASN, M.D. Leonard S. Schleifer David R. Epstein Yvonne L. Greenstreet Timothy Van Hauwermeiren EMBA,
Ratings
SXTP VRTX REGN SGEN ALNY ARGX
Quant Rating Score 2 2 4 3 1 2
Quant Rating Sell Sell Buy Neutral Strong Sell Sell
Trading
SXTP VRTX REGN SGEN ALNY ARGX
Last Close $2.38 $459.62 $547.36 $228.74 $331.91 $543.48
High 52 $3.45 $516.74 $1201.76 $228.74 $331.91 $671.75
Low 52 $0.09 $396.64 $482.92 $228.74 $224.58 $435.84
Price vs. 52 Week High -31.01 % -11.05 % -54.45 % 0 % 0 % -19.09 %
Price vs. 52 Week Low 2544.44 % 15.88 % 13.34 % 0 % 47.79 % 24.7 %
Total Return
SXTP VRTX REGN SGEN ALNY ARGX
1 Month Return -18.49 % 2.02 % 10.98 % 0 % 10.33 % -7.24 %
3 Month Return 34.46 % -3.16 % -4.55 % 0 % 40.79 % -2.1 %
6 Month Return 87.4 % 14.19 % -23.58 % 0 % 42.36 % -15.79 %
9 Month Return 128.85 % 0.95 % -45.96 % 0 % 23.85 % 2.55 %
YTD Return 84.5 % 14.13 % -23.16 % 0 % 41.05 % -11.63 %
1 Year Return 917.09 % -3.15 % -47.08 % 0 % 32.22 % 24.7 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
SXTP VRTX REGN SGEN ALNY ARGX
Dividend Yield Percentage (TTM) - - 0.32 % - - -
Dividend Paid and Capex Coverage Ration (TTM) -34.53 % -3.53 % 3.85 % -5.87 % -1.49 % -44.32 %
Dividend Per Share (TTM) - - 1.76 % - - -
Payout Ratio (TTM) - - 2.08 % - - -
Growth
SXTP VRTX REGN SGEN ALNY ARGX
Asset Growth -26.01 % -0.87 % 36.55 %
Gross Profit Growth 200.83 % 10.25 % 77.08 %
Revenue Growth 139.61 % 11.66 % 78.6 %
Revenue 3 Year 565.98 % 45.6 % 275.84 %
Revenue 5 Year 254.26 % 163.93 % 1701.04 %
Revenue 10 Year 254.26 % 1632.15 % 5950.81 %
EBIT Growth -420.49 % -93.69 % 128.87 %
Net Income Growth -111.04 % -114.8 % 382.34 %
Net Income 3 Yeari Growth Per Share -2277.34 % -122.89 % 274.39 %
Net Income 5 Yeari Growth Per Share -3231.81 % -145.38 % 396.61 %
Net Income 10 Yeari Growth Per Share -3231.81 % 33.84 % 938.02 %
Operating Income Growth -88.47 % -106.08 % 94.91 %
Operating Cash Flow Growth (CFG) -24.33 % -113.93 % 80.31 %
Operating 3 Year CFG -10967.16 % -118.65 % 88.36 %
Operating 5 Year CFG -42839.64 % -131.3 % -135.21 %
Operating 10 Year CFG -42839.64 % 12.43 % -64 %
EPS Growth -1852.63 % -114.8 % 369.77 %
EPS Diluted Growth -1852.63 % -114.97 % 347.67 %
Book Value Per Share 605.63 % -6.59 % 28.16 %
Share Holder 3 Year Equity Growth Per Share 392 % 62.6 % 85.14 %
Share Holder 5 Year Equity Growth Per Share 393.28 % 168.85 % 200.53 %
Share Holder 10 Year Equity Growth Per Share 393.28 % 1265.7 % 1039.11 %
Dividend Per Share Growth - - -
Dividend 3 Year Growth Per Share - - -
Dividend 5 Year Growth Per Share - - -
Dividend 10 Year Growth Per Share - - -
Debt Growth -9.72 % 116.42 % 95.27 %
Free Cash Flow Growth -25.12 % -124.1 % 67.46 %
Updated On 31 Dec 2024 31 Dec 2024 31 Dec 2024
Profitability
SXTP VRTX REGN SGEN ALNY ARGX
Gross Profit Margin TTM 40.1 % 86.03 % 84.94 % 79.1 % 86.01 % 46.33 %
Return on Assets TTM -171.53 % -4.32 % 11.98 % -16.61 % -6.4 % 13.45 %
Return on Equity TTM -238.18 % -6.25 % 14.77 % -20.8 % -509.33 % 16.83 %
Return on Capital Employed TTM -246.54 % -3.89 % 11.35 % -21.46 % -3.68 % -0.5 %
Net Income Per EBT TTM 99.94 % 329.41 % 90.27 % 101.33 % 75.89 % 25990.14 %
EBT Per Ebit TTM 99.68 % 40.44 % 129.3 % 98.26 % 308.03 % -11.64 %
EBIT Per Revenue TTM -1570.69 % -6.69 % 27.37 % -31.24 % -4.91 % -1.24 %
Cash Flow To Debt Ratio TTM -3931.77 % -59.44 % 146.15 % -1043.73 % -3.47 % -201.37 %
Receivables Turnover TTM 1.34 6.15 2.53 3.91 5.62 2.36
Payables Turnover TTM 0.34 3.49 3.01 1.97 3.37 2.39
Inventory Turnover TTM 0.51 1.14 0.66 0.96 5.01 2.93
Fixed Asset Turnover TTM 420.68 % 421.34 % 300.07 % 665.41 % 337.41 % 5106.8 %
Asset Turnover TTM 10.96 % 48.51 % 37.52 % 53.41 % 55.72 % 35.83 %
Operating Cash Flow Per Share TTM -4.76 -3.82 37.05 -2.46 -0.35 -1.07
Free Cash Flow Per Share TTM -4.89 -4.9 28.3 -2.88 -0.58 -1.09
Cash Per Share TTM 268.92 % 2413.86 % 7825.12 % 939.52 % 2024.29 % 4688.94 %
Operating Cash Flow Sales Ratio TTM -931.51 % -8.83 % 28.06 % -23.12 % -1.92 % -3.54 %
Free Cash Flow Operating Cash Flow Ratio TTM 102.9 % 128.33 % 76.4 % 117.04 % 167.11 % 102.26 %
Cash Flow Coverage Ratios TTM -3931.77 % -59.44 % 146.15 % -1043.73 % -3.47 % -201.37 %
Price To Free Cash Flows Ratio TTM -0.55 -92.97 19.24 -81.26 -550.45 -434.25
Price To Operating Cash Flows Ratio TTM -0.49 -119.36 14.77 -93.1 -914.84 -515.98
Price Cash Flow Ratio TTM -0.49 -119.36 14.77 -93.1 -914.84 -515.98
Income Statement (TTM)
SXTP VRTX REGN SGEN ALNY ARGX
Revenue $0B $11.02B $14.2B $1.96B $2.25B $2.19B
Gross Profit $0B $9.49B $12.23B $1.55B $1.92B $1.96B
Gross Profit Ratio 36.67% 86.11% 86.13% 79.1% 85.62% 89.62%
EBITDA $-0.01B $0.49B $5.32B $-0.62B $-0.18B $0.11B
Net Income $-0.01B $-0.54B $4.41B $-0.61B $-0.28B $0.83B
EPS Diluted -18.55 -2.08 38.34 -3.3 -2.16 12.78
Balance Sheet (MRQ)
SXTP VRTX REGN SGEN ALNY ARGX
Long Term Debt $0B $1.66B $1.98B $0.04B $0B $0.03B
Total Liabilities $0B $6.12B $8.41B $0.87B $4.17B $0.7B
Total Equity $0B $16.41B $29.35B $2.8B $0.07B $5.5B
Total Investments $0B $6.65B $15.42B $1.42B $1.73B $1.93B
Total Debt $0B $1.75B $2.7B $0.04B $1.3B $0.04B
Total Assets $0.01B $22.53B $37.76B $3.67B $4.3B $6.2B
Cash Flow Statement (TTM)
SXTP VRTX REGN SGEN ALNY ARGX
Net Income $-0.01B $-0.54B $4.41B $-0.61B $-0.28B $-0.02B
Inventory $0B $-0.52B $-0.62B $-0.23B $0.01B $-0.09B
Dividends Paid $0B $0B $0B $0B $0B $0B
Operating Cash Flow $-0.01B $-0.49B $4.42B $-0.45B $-0.01B $-0.08B
Capital Expenditure $-0B $-0.3B $-0.76B $-0.08B $-0.03B $-0.07B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 42.85
AARD Aardvark Therapeutics, Inc. Common Stock 13.92
ABCL AbCellera Biologics Inc. 3.8
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.89
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 1.16
ABPWW 0.0222
ABSI Absci Corporation 2.77
ABUS Arbutus Biopharma Corporation 3.24
ABVC ABVC BioPharma, Inc. 3.11
ABVX Abivax SA American Depositary Shares 7.96
ACAD ACADIA Pharmaceuticals Inc. 20.95
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.607
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 2.18
ACIU AC Immune SA 2.07
ETFs With Exposure to SXTP
Ticker ETF Name Weight Percentage Price
VXF Vanguard Extended Market Index Fund 0 197.5
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 149.82
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 149.83
VEMPX Vanguard Extended Market Index InstlPlus 0 369.73
Unlock